Molecular Docking and Dynamics Simulation Revealed Ivermectin as Potential Drug against


Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
03 Oct 2021
Historique:
received: 02 08 2021
revised: 26 09 2021
accepted: 29 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 27 10 2021
Statut: epublish

Résumé

Urogenital schistosomiasis is caused by

Identifiants

pubmed: 34684095
pii: medicina57101058
doi: 10.3390/medicina57101058
pmc: PMC8539496
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0
Vascular Endothelial Growth Factor A 0
Ivermectin 70288-86-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Scientific Research Deanship at University of Ha'il-Saudi Arabia
ID : RG-20128

Références

Infect Agent Cancer. 2013 May 24;8(1):19
pubmed: 23705833
Cancer. 2004 Sep 15;101(6):1364-74
pubmed: 15368324
Trop Med Int Health. 2001 Nov;6(11):864-73
pubmed: 11703840
Pharmacol Res. 2021 Jan;163:105207
pubmed: 32971268
Mem Inst Oswaldo Cruz. 2010 Jul;105(4):436-9
pubmed: 20721486
Mayo Clin Proc. 2011 Jun;86(6):561-83
pubmed: 21628620
J Antimicrob Chemother. 1994 Aug;34(2):195-203
pubmed: 7814280
Cancer Lett. 2004 Mar 8;205(1):15-21
pubmed: 15036656
Eur J Immunol. 2003 Oct;33(10):2764-72
pubmed: 14515260
J Antibiot (Tokyo). 2021 Jun 15;:
pubmed: 34127807
J Biomol Struct Dyn. 2021 Feb 8;:1-22
pubmed: 33554773
Front Oncol. 2021 Apr 29;11:670804
pubmed: 33996598
J Cancer Res Ther. 2014 Oct-Dec;10(4):1057-62
pubmed: 25579554
Oncogene. 2017 Jan 12;36(2):254-262
pubmed: 27270429
J Egypt Natl Canc Inst. 2020 Nov 30;32(1):44
pubmed: 33252773
Nat Rev Cancer. 2008 Aug;8(8):579-91
pubmed: 18596824
Int Urol Nephrol. 2004;36(3):401-5
pubmed: 15783115
J Chem Inf Model. 2005 Jan-Feb;45(1):160-9
pubmed: 15667141
Cancer Lett. 1992 Jul 10;64(3):225-33
pubmed: 1638515
Pharmacol Ther. 2014 Apr;142(1):126-39
pubmed: 24316259
Biotechnol Adv. 2018 Nov 1;36(6):1730-1737
pubmed: 29305894
Biochem Biophys Res Commun. 2016 Nov 18;480(3):415-421
pubmed: 27771251
EMBO Mol Med. 2014 Aug 20;6(10):1263-78
pubmed: 25143352
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(2):13-28
pubmed: 21321478
Eur Urol. 2020 Dec;78(6):893-906
pubmed: 32972792
Biomolecules. 2019 Nov 13;9(11):
pubmed: 31766246
Ther Adv Med Oncol. 2017 Jan;9(1):33-45
pubmed: 28203296
J Agric Food Chem. 2016 Sep 14;64(36):6895-902
pubmed: 27551889
Med Sci (Basel). 2020 Mar 13;8(1):
pubmed: 32183076
Clin Microbiol Rev. 1999 Jan;12(1):97-111
pubmed: 9880476
Ann Med Health Sci Res. 2015 Mar-Apr;5(2):93-102
pubmed: 25861527
J Hematol Oncol. 2018 Feb 20;11(1):23
pubmed: 29458389
Antioxidants (Basel). 2021 Apr 29;10(5):
pubmed: 33946704
Thromb Haemost. 1998 Jul;80(1):171-5
pubmed: 9684805
J Biomol Struct Dyn. 2021 Jul 9;:1-53
pubmed: 34243689
APMIS. 2017 Dec;125(12):1056-1062
pubmed: 28960560
Int J Mol Sci. 2014 Aug 15;15(8):14298-312
pubmed: 25196524
J Exp Clin Cancer Res. 2019 Jun 18;38(1):265
pubmed: 31215501
Med Chem. 2007 Mar;3(2):187-97
pubmed: 17348856
BMC Public Health. 2020 Nov 11;20(1):1693
pubmed: 33176751
Nat Rev Urol. 2009 May;6(5):281-9
pubmed: 19424176
Cancer Manag Res. 2013 Jun 11;5:103-15
pubmed: 23807861
J Adv Res. 2013 Sep;4(5):433-44
pubmed: 25685450
J Clin Invest. 2006 Oct;116(10):2610-21
pubmed: 17016557
Front Pharmacol. 2020 Oct 06;11:529881
pubmed: 33117153
Environ Pollut. 2017 Jan;220(Pt B):1127-1137
pubmed: 27852506
Oncotarget. 2017 Jul 11;8(28):45981-45993
pubmed: 28526807
PLoS One. 2015 Mar 23;10(3):e0120426
pubmed: 25799586
Ann N Y Acad Sci. 2018 Aug;1425(1):19-37
pubmed: 29888790
Free Radic Biol Med. 2019 Feb 1;131:356-369
pubmed: 30557609
Cancers (Basel). 2021 Jun 26;13(13):
pubmed: 34206772
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28674061
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28264841
Pharmacol Ther. 1985;29(1):129-56
pubmed: 3914644
Curr Pharm Des. 2006;12(3):387-94
pubmed: 16454752
ACS Infect Dis. 2020 Sep 11;6(9):2524-2531
pubmed: 32786284

Auteurs

Arif Jamal Siddiqui (AJ)

Department of Biology, College of Science, University of Hail, Hail 2440, Saudi Arabia.

Mohammad Faheem Khan (MF)

Department of Biotechnology, Era's Lucknow Medical College, Era University, Lucknow 226003, India.

Walid Sabri Hamadou (WS)

Department of Biology, College of Science, University of Hail, Hail 2440, Saudi Arabia.

Manish Goyal (M)

Molecular Parasitology and Immunology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.

Sadaf Jahan (S)

Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia.

Arshad Jamal (A)

Department of Biology, College of Science, University of Hail, Hail 2440, Saudi Arabia.

Syed Amir Ashraf (SA)

Department of Clinical Nutrition, College of Applied Medial Sciences, University of Hail, Hail 2440, Saudi Arabia.

Pankaj Sharma (P)

Molecular Parasitology and Immunology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.

Manojkumar Sachidanandan (M)

Department of Oral Radiology, College of Dentistry, University of Hail, Hail 2440, Saudi Arabia.

Riadh Badraoui (R)

Department of Biology, College of Science, University of Hail, Hail 2440, Saudi Arabia.
Section of Histology-Cytology, Medicine Faculty of Tunis, University of Tunis El Manar, Tunis 1017, Tunisia.

Kundan Kumar Chaubey (KK)

Department of Biotechnology, Academic Block VI, GLA University, Mathura 281406, India.

Mejdi Snoussi (M)

Department of Biology, College of Science, University of Hail, Hail 2440, Saudi Arabia.
Laboratory of Genetics, Biodiversity and Valorization of Bio-Resources (LR11ES41), University of Monastir, Higher Institute of Biotechnology of Monastir, Avenue Tahar Haddas BP74, Monastir 5000, Tunisia.

Mohd Adnan (M)

Department of Biology, College of Science, University of Hail, Hail 2440, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH